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Abstract
How the microbiota affects health and disease is a crucial question. In mice, gut Clostridium bacteria are potent inducers of
colonic interleukin (IL)-10-producing Foxp3 regulatory T cells (Treg), which play key roles in the prevention of colitis and in
systemic immunity. In humans, although gut microbiota dysbiosis is associated with immune disorders, the underlying
mechanism remains unknown. In contrast with mice, the contribution of Foxp3 Treg in colitis prevention has been
questioned, suggesting that other compensatory regulatory cells or mechanisms may exist. Here we addressed the
regulatory role of the CD4CD8 T cells whose presence had been reported in the intestinal mucosa and blood. Using colonic
lamina propria lymphocytes (LPL) and peripheral blood lymphocytes (PBL) from healthy individuals, and those with colon
cancer and irritable bowel disease (IBD), we demonstrated that CD4CD8aa (DP8a) T lymphocytes expressed most of the
regulatory markers and functions of Foxp3 Treg and secreted IL-10. Strikingly, DP8a LPL and PBL exhibited a highly skewed
repertoire toward the recognition of Faecalibacterium prausnitzii, a major Clostridium species of the human gut microbiota,
which is decreased in patients with IBD. Furthermore, the frequencies of DP8a PBL and colonic LPL were lower in patients
with IBD than in healthy donors and in the healthy mucosa of patients with colon cancer, respectively. Moreover, PBL and
LPL from most patients with active IBD failed to respond to F. prausnitzii in contrast to PBL and LPL from patients in
remission and/or healthy donors. These data (i) uncover a Clostridium-specific IL-10-secreting Treg subset present in the
human colonic LP and blood, (ii) identify F. prausnitzii as a major inducer of these Treg, (iii) argue that these cells contribute
to the control or prevention of colitis, opening new diagnostic and therapeutic strategies for IBD, and (iv) provide new tools
to address the systemic impact of both these Treg and the intestinal microbiota on the human immune homeostasis.
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Introduction
The gastrointestinal tract hosts a huge number of bacteria
species. In mice, these bacteria play a major role in shaping local
and systemic immune responses, notably by the induction of
different effector and regulatory T cell subsets, whose adequate
balance is required for the maintenance of gut homeostasis [1]. It
may be postulated that this balance relies on the microbiota
composition, as suggested by the observation that dysbiosis are
frequent in chronic immune disorders, especially Inflammatory
Bowel Disease (IBD) [2–4]. Nonetheless, data on how the
microbiota composition may impact the disease process are still
lacking and in particular the existence and potential role of
microbiota-induced regulatory T cells (Treg) in humans remain to
be addressed [5].
CD4 T cells that express the transcription factor fork head box
p3 (Foxp3) are the best-known Treg. Some differentiate in the
thymus in response to self-antigens and prevent self-reactive
immune responses [6,7]. Others differentiate in the periphery
under various conditions including chronic challenges by non-self
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antigens, such as commensal bacteria, and are strong contributors
to tissue homeostasis [8]. In mice, a recent study highlighted that
Clostridium bacteria are outstanding inducers of Foxp3 Treg in the
colonic mucosa [9]. Additionally, some of these Treg expressing
microbiota-specific T cell receptor (TCR) suggested that their
induction involved the cognate recognition of bacterial antigens
[10]. Foxp3 Treg are also present in the human gut mucosa, but
their exact origin, distribution, and contribution to IBD preven-
tion remain to be elucidated. Given that individuals with FOXP3
mutations do not always develop colitis and that intestinal
inflammation is not associated with a decrease in the number of
Foxp3 Treg, it has been postulated that non-Foxp3 Treg or other
suppressive mechanisms may regulate colon immune homeostasis
in humans [11,12].
Interleukin (IL)-10-secreting Foxp3 negative lymphocytes cor-
respond to a heterogeneous population that remains poorly
characterized, especially in humans [13,14]. In mice, several
subsets of IL-10-secreting lymphocytes have been described in the
small intestine [1], among which are double positive CD4CD8aa
intraepithelial lymphocytes (IELs), which may prevent Th1-
induced intestinal inflammation, in an IL-10-dependent manner
[15]. In contrast, these cells are absent in the lamina propria (LP)
of the mouse colonic mucosa, where most IL-10-secreting
lymphocytes express Foxp3 [16]. In humans, genetic studies
pointed to an important role of IL-10 in the prevention of
intestinal inflammation [17,18], but the abundance and distribu-
tion of IL-10-secreting non-Foxp3 and Foxp3 lymphocytes in the
gut and the relative contribution of these cells to gut homeostasis
remain poorly documented.
At least two subsets of double positive (DP) T lymphocytes,
CD4CD8abhigh and CD4CD8aa (CD8alow lacking CD8b) have
been described in the human blood [19,20]. The latter subset has
also been described in the intestinal mucosa of patients with and
without IBD where it is relatively abundant compared with blood
[21,22]. However, the functional significance of these DP subsets
has remained unclear to date, and, in particular, a putative
regulatory role of these cells has not been studied.
Here we showed that double positive CD4CD8aa (DP8a) T
lymphocytes from the human colonic lamina propria (DP8a LPL)
and blood (DP8a peripheral blood lymphocytes [PBL]) represent a
yet undescribed subset of Foxp3-negative T lymphocytes that
share all the regulatory functions of Foxp3 Treg and secrete IL-10.
We also showed that these cells are decreased in the blood of
patients with IBD, as compared with healthy donors, and in the
colonic mucosa of patients with IBD compared with the healthy
colonic mucosa of patients with colon cancer (CC). Importantly,
we identified the induction of DP8a Treg by the gut commensal
bacteria F. prausnitzii (F) as one of the mechanisms that may
explain the impact of a balanced microbiota on the prevention or
the control of IBD in particular, and on human health in general.
Results
Double Positive CD4CD8aa T lymphocytes Are
Frequently Found in the Human Colonic Lamina Propria
We analyzed the co-expression of CD4 and either CD8a or
CD8b by T cells isolated from the epithelium or LP of healthy
colonic mucosa from patients with CC. A significant fraction of
CD3 LPL co-expressed CD4 and CD8a but not CD8b. The
CD8a level expressed by these cells was variable and lower than
that on CD8ab T cells (Figure 1a). CD4CD8aa LPL, hereafter
referred to as DP8a LPL, were then quantified (Figure 1b). They
made up a mean of 8.5% (range 3.1–16.2) of CD3 LPL and 13.3%
(range 5.9–24.8) of CD4 LPL. In the epithelium, smaller fractions
of T cells co-expressed CD4 and CD8a (mean 2.4%, range 0.7–
5.6), and some of these cells expressed high levels of CD8a or
CD8b (Figure S2), likely corresponding to the CD4CD8ab colonic
IEL subset that we previously described [23].
To assess the stability and polyclonality of DP8a LPL, LPL
populations freshly dissociated from four donors were expanded by
a single polyclonal stimulation. The populations obtained
contained similar fractions of DP8a cells as the original LPL
(unpublished data). The CD4 (CD8a neg) and the CD4CD8a cells
were then FACS-sorted, to derive pure DP8a and CD4 LPL lines
by polyclonal expansion. At any time during culture the phenotype
of the sorted cell lines was unchanged (Figure 1c and unpublished
data). We then asked the degree of polyclonality of DP8a LPL.
Two of these LPL lines (C101 and C114), obtained by a single
stimulation of freshly isolated LPL expressed, respectively, 11 and
21 Vb chains (out of the 25 tested). Moreover, DP8a LPL sorted
from freshly dissociated LPL from one donor (C150) expressed 22
out of the 25 Vb analyzed (Table S1). Therefore, DP8a T cells
represent in vivo an abundant and polyclonal subset of colonic
LPL, distinct from the CD4 subset by a stable expression of CD8a.
DP8a Colonic LPL Exhibit a Treg Phenotype and
Functions
It had been hypothesized that CD4CD8 gut lymphocytes might
be regulatory cells [22]. We therefore asked whether DP8a colonic
LPL had a Treg phenotype, compared with their CD4 homo-
logues. Both freshly dissociated DP8a LPL (Figure 2a) and DP8a
LPL lines (Figure 2b) exhibited the same Treg phenotype. They
differed from their autologous CD4 counterparts by the expression
or over-expression of Foxp3-Treg markers (e.g., CD25, CTLA4,
GITR, LAG-3), activation and co-stimulation markers (e.g.,
CD80, CD86, CD40L), and adhesion markers (e.g., LFA-1,
LFA3, and ICAM-1). However, in contrast to Foxp3-Treg, they
lacked Foxp3 and, as cell lines, they expressed the IL-7R (CD127).
The DP8a LPL lines lacked the gut homing/localization
molecules (CCR9, a4b7, and CD103). In contrast, these molecules
were expressed by a significant fraction of freshly dissociated DP8a
LPL (Figure S3a).
To further characterize these cells, we studied their cytokine
profile. The DP8a LPL lines and freshly dissociated DP8a LPL
Author Summary
It has become evident that bacteria in our gut affect health
and disease, but less is known about how they do this.
Recent studies in mice showed that gut Clostridium
bacteria and their metabolites can activate regulatory T
cells (Treg) that in turn mediate tolerance to signals that
would ordinarily cause inflammation. In this study we
identify a subset of human T lymphocytes, designated
CD4CD8aa T cells that are present in the surface lining of
the colon and in the blood. We demonstrate Treg activity
and show these cells to be activated by microbiota; we
identify F. prausnitzii, a core Clostridium strain of the
human gut microbiota, as a major inducer of these Treg
cells. Interestingly, there are fewer F. prausnitzii in
individuals suffering from inflammatory bowel disease
(IBD), and accordingly the CD4CD8aa T cells are decreased
in the blood and gut of patients with IBD. We argue that
CD4CD8aa colonic Treg probably help control or prevent
IBD. These data open the road to new diagnostic and
therapeutic strategies for the management of IBD and
provide new tools to address the impact of the intestinal
microbiota on the human immune system.
CD4CD8aa Cells: Microbiota-Induced Treg
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expressed Tbet and Gata3 (Figures 2c and S3b) and lacked
RORcc (Figure 2c and unpublished data) by 100% of their cells.
Moreover, upon polyclonal activation, the DP8a LPL lines
secreted tumour necrosis factor-alpha (TNF-a) and interferon
gamma (IFN-c) (approximately 50% cells), but little if any IL-2
(Figure 2d) and no IL-4, IL-5, IL-13, IL-17, or IL-22 (unpublished
data). Ex vivo, the DP8a LPL exhibited the same cytokine profile
as the DP8a cell lines (Figure S3c). Importantly, as shown by
ELISA (Figure 2e) and quantitative PCR (Figure S3d), activated
DP8a LPL lines, but not their CD4 counterparts, secreted IL-10.
Therefore, DP8a LPL exhibit a phenotype and a cytokine profile
of Treg but lack Foxp3. We then addressed the regulatory
potential of these cells in vitro.
Regulatory Properties of Human DP8a LPL
Similarly to Foxp3 Treg [24], the DP8a LPL lines inhibited the
maturation of dendritic cells (DCs), as revealed by the inhibition of
CD86, CD83 (Figure 3a), and CD80 (unpublished data) up-
regulation, in a CTLA-4- and LFA-1-dependent manner
(Figure 3a). The DP8a LPL lines also inhibited CD4 T cell
proliferation induced by anti-CD3 and anti-CD28 antibody at all
effector-target ratios used (Figure 3b and 3c), and this inhibition
was partially blocked by an anti-IL-10 but not by an anti-
transforming growth factor (TGF)-bR-antibody (Figure 3d). In
contrast, the CD4 LPL lines induced DC maturation (Figure 3a)
and failed to inhibit the proliferation of CD4 lymphocytes
(Figures 3b and S4a). Notably, contrasting with Foxp3 and Tr1
Treg, the suppressive DP8a LPL proliferated upon CD3 activation
in the absence of IL-2 addition, during the inhibition of CD4 T
cell proliferation (Figure S4b).
DP8a LPL Specifically Reacted with a Gut Commensal
Bacteria: F. prausnitzii
Bacteria belonging to the Clostridium cluster IV and XIV have
been shown to induce Foxp3 Treg in the mouse colonic LP [9].
We therefore investigated if this could be the same for DP8a
colonic LPL Treg. We first assessed the microbiota reactivity of
DP8a LPL lines using four bacteria strains: F. prausnitzii (F), a
major human gut bacterium of the Clostridium IV group, that is
present at a decreased level in the faeces of patients with IBD and
was shown to induce IL-10 expression by peripheral blood
mononuclear cell (PBMC) [2,25], Bacteroides thetaiotaomicron (B), and
Lactobacillus casei (L), which may promote Foxp3 Treg differenti-
ation/expansion in mice [1], and Escherichia coli (E), a potential
pathobiont. The DP8a LPL lines and their CD4 counterparts
were incubated with the bacteria alone or with a mix of allogeneic
monocytes (as monocytes from the patients with cancer were
usually not available) previously loaded overnight with each
bacterium. The LPL lines (DP8a and CD4) did not proliferate or
secrete cytokines when incubated with the bacteria alone
(unpublished data). In contrast, the DP8a lines responded to
monocytes loaded with F but not or much less to monocytes alone
and to monocytes loaded with B, L, or E bacteria, while the CD4
LPL lines did not respond specifically to F nor to the other
Figure 1. DP8a are frequently found in the lamina propria of healthy colon mucosa. Freshly dissociated CD3 LPL and cell lines were
analyzed by flow cytometry for the co-expression of CD4 and either CD8a or CD8b. (a) Representative dot plots and frequencies of CD4 T cells co-
expressing CD8a or CD8b among the CD3 LPL from 12 donors; ***p,0.001 (paired t-test). (b) Frequencies of CD4CD8aa cells among the CD3 or
CD3CD4 LPL (n=18). (c) Stable co-expression of CD4 and CD8a but not CD8b, by a cell line (representative of four) obtained from FACS-sorted DP8a
colonic LPL, after several transfers in culture.
doi:10.1371/journal.pbio.1001833.g001
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bacteria. This was shown both by a proliferation assay (Figure 4a
and 4b) and by intracellular IFN-c and IL-10 labelling (Figures 4c
and S4c). We also observed in these experiments that DP8a LPL
responses to F were suppressed by an anti-MHC class-II antibody
but not by an irrelevant antibody (Figure 4a and 4c). This finding
suggested that F recognition by DP8a LPL could be TCR
dependent. However it could also be due to F-restricted
superantigens. To further assess this important point, we
compared the capacity of antibodies to CD4, CD8, MHC-I,
MHC-II, HLA-DP, HLA-DQ, and HLA-DR to block the
response of DP8a LPL to F presentation by a mix of three
allogeneic monocytes and we analyzed the response of HLA class
Figure 2. Regulatory phenotype and cytokine profile of DP8a LPL. (a) Comparison of the phenotypes of DP8a and CD4 lymphocytes among
CD3 LPL freshly dissociated from healthy colonic mucosa (representative of three) (b) Phenotypes of autologous DP8a and CD4 LPL lines
(representative of three pairs). (c) Expression of transcription factors by a DP8a cell line (representative of three) measured by intracellular labelling.
(d) Intracellular staining for TNF-a, IFN-c, and IL-2 in a DP8a LPL line (representative of three) stimulated for 5 h with an anti-CD3 antibody in the
presence of BFA. (e) IL-10 in the supernatants of DP8a (white circles) and CD4 (black circles) LPL lines (n= 3) activated by an anti-CD3 antibody for
48 h as measured by ELISA (three experiments in triplicate for each cell line).
doi:10.1371/journal.pbio.1001833.g002
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II-typed LPL lines to monocytes of known HLA-DP, -DQ, and -
DRb1 genotypes (Table S2). As expected from TCR-dependent
responses, cytokine responses of the LPL lines to F-loaded
monocytes were totally inhibited by the anti-MHC-II and -CD4
but not by the anti-MHC-I and -CD8 antibodies and were
inhibited at different levels by the anti-HLA-DP, -DQ, and -DR
antibodies (Table 1). In addition, the LPL lines reacted to F
presentation by the monocytes that shared at least one HLA class
II allele but did not react with those that did not (with the
exception of the response of the LPL line C192 to monocyte 5,
Figure 3. Regulatory functions of DP8a LPL lines. (a) DP8a LPL lines blocked the maturation of immature DC induced by activated CD4
lymphocytes, as shown by the inhibition of CD83 and CD86 up-regulation, and this inhibition was partially neutralised by anti-CTLA-4 and ant-LFA-1
antibodies. Immature DC were incubated for 5 d with CD4 PBL lines (expressing CD40L) in the presence or absence of DP8a LPL lines and anti-CTLA4
or anti-LFA-1 antibodies. The CD83 and CD86 expression levels were measured on gated CD3 negative cells: representative histograms and median
for the CD83 and CD86 relative fluorescence intensity (RFI); (n=6, two experiments performed with three cell lines); ***p,0.001, **p,0.01, and *p,
0.05 (paired t-test). (b) Inhibition of the proliferative response of CD4 PBL by the DP8a LPL and CD4 LPL lines C114, C139 as measured by CFSE
dilution. CD4 PBL sorted from healthy donor PBMC were stimulated with anti-CD3 and anti-CD28 in the presence or absence of DP8a LPL lines for 5 d
at a ratio of 1:1: representative cytometry data and histograms showing the CFSE dilution in CD8 negative lymphocytes: unstimulated (white
histograms), stimulated (black histograms) stimulated in the presence of DP8a LPL (grey histograms), and stimulated in the presence of CD4 LPL
(hachured histograms) (n=12: six experiments done with two DP8a LPL lines); ***p,0.001 (paired t-test). (Only one experiment performed with the
CD4 LPL lines) (c) Percent inhibition of CD4 lymphocyte proliferation by DP8a LPL lines at the indicated E:T ratios. (d) Percent suppression of CD4
lymphocyte proliferation by DP8a LPL at a ratio of 1:1 in the presence or absence of anti-IL-10 or anti-TGF-bR blocking antibodies; ***p,0.001 (paired
t-test).
doi:10.1371/journal.pbio.1001833.g003
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Figure 4. DP8a LPL specifically respond to the gut commensal bacterium F. prausnitzii. Flow cytometry analysis of the proliferative
response (VPD dilution and FlowJo analysis) of DP8a LPL (a) or CD4 LPL lines (b) after 3 d of co-culture with allogeneic monocytes alone or loaded
overnight with F in the presence or absence of an anti-MHC class-II antibody or of an irrelevant antibody (IgG), or with monocytes loaded with B, L, or
E: representative cytometry data and mean percentage of VPD low cells (n=6: two independent experiments performed with three DP8a LPL lines);
**p,0.01 (paired t-test). (c) Flow cytometry analysis of the IFN-c and IL-10 responses of DP8a LPL lines (n= 4) after 6 h of stimulation by monocytes,
CD4CD8aa Cells: Microbiota-Induced Treg
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which may be due to a cross-presentation between two similar
alleles such as DQ*0301 and *0303) (Tables 2 and S2). Moreover,
not supporting the superantigen hypothesis, we observed that most
Vb expressed by F-reactive DP8a LPL (identified by the co-
labelling of intracellular cytokines and of Vb in F-stimulated DP8a
LPL) were also expressed by the CD4 LPL lines and that these
cells did not respond to F-loaded monocytes (unpublished data).
These results indicated that DP8a LPL recognized F antigens in
the context of autologous HLA DP, DQ, or DR alleles and
therefore in a TCR-dependent manner.
Recent reports have indicated that IL-10-secreting Foxp3 Treg
could not be induced in mice by a single Clostridium species but
only by a pool of Clostridium [9,26]. Although these inductions had
not been shown so far to be antigen dependent, this finding raised
the question whether F recognition by DP8a Treg was species
specific or cluster specific. We assessed this using nine additional
Clostridium strains, Suboligranulum variabile, Roseburia intestinalis, C.
coccoides, C. leptum, Ruminococcus gnavus, C. ramosum, C. symbosium, C,
boltea, and Anaerotruncus colihominis, which are abundant in human
faeces. While the LPL lines (n=3) systematically responded to F, no
response to these bacteria was observed (Table 3). These results
indicated that F-reactive DP8a LPL do not respond to a widely
shared Clostridium antigen and thus may be F-specific.
We next investigated which proportion of ex vivo colonic DP8a
LPL could be F-specific. To assess this, three freshly dissociated LPL
populations were stimulated by a mix of F-loaded allogeneic
monocytes, and pure populations of freshly sorted DP8a and CD4
LPL from one patient with colorectal cancer (C150) were stimulated
by F-loaded autologous monocytes. We measured the proportions
of DP8a cells, and of their CD4 counterparts, which divided in
response to F-loaded but not to E-loaded monocytes nor to
monocytes alone. A mean of 45% (range 20–80) of DP8a LPL
divided specifically to F but not to E, while the CD4 LPL did not
proliferate (Figure 4d). It has to be stressed that the fraction of F-
specific cells was likely underestimated in three of these LPL
populations as they were evaluated with allogeneic antigen-
presenting cells (APCs) (Figure 4d black symbols). Interestingly,
when autologous monocytes were used to present F to a pure
population of DP8a LPL (Figure 4d, grey circle and right panels),
80% of these cells responded to F.We then assessed, with short-term
cultured LPL lines C101 and C114 and with the freshly sorted
DP8a LPL population (C150), the Vb diversity of F-reactive DP8a
lymphocytes. Vb labelling showed that the F-reactive DP8a LPL
expressed the majority of the Vb of the total DP8a populations,
respectively, for C101, C114, and C150 LPL: 9/11 Vb and 1/3 Va,
16/21 Vb and no Va, and 23/23 Vb (Table S1). In sum, these data
demonstrated that DP8a colonic LPL are highly polyclonal and,
considering that F antigen presentation by allogeneic monocytes
was suboptimal, they suggested that the TCR repertoire of these
cells is highly skewed towards the recognition of F. prausnitzii.
DP8a Regulatory T Cells Are Present amongst PBL
Variable proportions and distinct subsets of double positive
CD4CD8 T cells have been described in the blood of patients and
healthy donors among which CD4CD8ab lymphocytes expressing
high levels of CD4, CD8a and CD8b, and CD4CD8aa
lymphocytes that expressed low levels of CD8a and no CD8b.
Nonetheless, very little is known about the repertoire and
immunological functions of these cells [19,27]. We confirmed that
CD4CD8alowPBL lacked CD8b and they will hereafter be
referred to as DP8a PBL. DP8a PBL represented a mean of
1.5% (range 0.1%–5.7%) of CD3 PBL and of 2.3% (range 0.1%–
7.8%) of CD4 PBL in healthy donors (Figures 5a and S5). It had
been reported that some DP PBL represent monoclonal T cell
expansions [27]. Therefore we first assessed ex vivo the
polyclonality of DP8a PBL from two donors, using 25 Vb
antibodies. DP8a PBL expressed 24 out of 25 Vb, suggesting that
they were polyclonal (Table S3). To determine whether these cells
could be Treg originating from the colonic mucosa, we next
assessed their expression of regulatory markers (CTLA4, CD25,
GITR, and LAG3), and their reactivity to F. Ex vivo, most DP8a
PBLs lacked regulatory markers (unpublished data). Nonetheless, a
significant percentage of these cells proliferated in an MHC class-
II dependent manner among PBMC cultured for 5 d with F (mean
divided cells 7.54% range 1%–22%), but not, or at much lower
levels, with B, L, and E (Figure 5b). Compared with DP8a PBL,
CD4 PBL yielded much lower proliferative responses to F
(Figure 5c) and did not respond to E (unpublished data).
Importantly, a majority of F-reactive DP8a PBL and of those
that did not respond to F in the proliferation assay expressed the
regulatory markers CTLA-4 and LAG-3, within 5 days of co-
culture with F while their CD4 counterparts did not (Figure 5d).
The fraction of DP8a PBL specific for F was re-analyzed using
pure DP8a and CD4CD25highCD127low (Foxp3+) PBL popula-
tions sorted from PBMC from healthy individuals stimulated by
autologous monocytes loaded with F or E or not loaded. As
observed previously with total PBMC, the DP8a, but not the CD4
PBL, proliferated in a specific manner to F-loaded monocytes
(mean 14.4% range 7.3–26.9) (Figure 5e). Therefore the mean
percent of F-specific cells among DP8a PBL may be estimated to
be above 15%.
This result raised the question of whether the F-specific DP8a
PBL might be a DP subset distinct from the F-non-responding
cells. To assess this, we asked whether F-reactive DP8a PBL might
be distinguished from the non-responding ones by their Vb. We
investigated this question using PBL lines enriched in DP8a cells
(DP8) by a single sorting. In these cells lines the DP8a cells
expressed 20 to 23 of the Vb tested (Table S3). We stimulated
these cell lines by monocytes loaded with F and determined the Vb
expressed by the F-reactive cells. As shown in Table S2, the F-
reactive DP8a cells (VPVlow) expressed the majority of the Vb
tested: 17/17 and 12/17. These data indicated that the repertoire
of F-specific DP8a PBL is diverse and not clearly distinct from that
of the total DP8a PBL population.
To investigate the regulatory potential of DP8a PBL, we
derived pure DP8a- and, as controls, pure CD4-PBL lines, by
FACS-sorting followed by polyclonal expansion, i.e., indepen-
dently of any stimulation by the bacteria. We also derived two
DP8a cell lines and one CD4 cell line with similar sort but starting
loaded overnight by F (1:5) in the presence or absence of anti MHC class-II antibody or of an irrelevant antibody, or not loaded, or loaded with B, L, or
E: representative response of the C139 DP8a LPL line and the percentages of cells secreting IL-10 or IFN- c or both in independent experiments (two
to seven experiments performed with four DP8a LPL lines: C114, black circles; C139, white circles; C192, white squares; and C140, black squares;
***p,0.001 (paired t-test). (d) Flow cytometry analysis of the proliferative response of freshly dissociated LPL from three donors stimulated by
allogeneic monocytes (black symbols) and of sorted DP8a and CD4 LPL from one donor (grey symbols) stimulated by autologous monocytes.
Responses were analyzed after 5 d of co-culture with monocytes alone or monocytes loaded overnight with F or E: mean percentage of F specific
divided cells (with deduction of the divided cells to monocytes alone) (calculated on FlowJo software) and representative cytometry data of the
proliferative response of the freshly sorted DP8a LPL population.
doi:10.1371/journal.pbio.1001833.g004
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from PBMC cultured 5 days with F. Under both conditions the
first sort yielded DP8a cells with a purity of 60%–70%. Pure DP8a
(Figure 6a) and CD4 PBL lines (unpublished data) were obtained
after a second or a third sort and polyclonal expansions. The
DP8a PBL lines lacked CD8b (Figure 6a) and expressed high
levels of CD25, CTLA-4, GITR, and LAG-3 in culture (Figure 6b),
and upon CD3 and CD28 stimulation secreted IL-10 (Figure 6c).
In contrast, their CD4 counterparts lacked CTLA-4 and GITR,
expressed CD25 and LAG-3 at lower levels (Figure 6b), and did
not secrete IL-10 (Figure 6c). The DP8a PBL lines inhibited the
proliferation of CD4 lymphocytes and the maturation of DCs
(Figure 6d and 6e) in contrast to their CD4 homologues
(unpublished data). Amongst DP8a PBL lines, between 9% and
31% of cells secreted IFN-c and/or IL-10 in response to a mix of
allogeneic monocytes (or autologous for one cell line) loaded with
F but not to monocytes loaded with the other bacteria, in a MHC
class-II-dependent (Figure 6f) and MHC class-II isotype-depen-
dent (unpublished data) manner, but did not secrete IL-2 or IL-4
(unpublished data). Importantly, in some experiments all the DP8a
cells that responded to F by secreting IFN-c also secreted IL-10
(Figure 6g), suggesting that the cytokine profile of these cells is
homogeneous. The CD4 PBL lines did not respond to F by
proliferation or cytokine secretion (unpublished data). Therefore,
DP8a PBL appear to be polyclonal and functionally homogeneous
populations of circulating Treg, distinct from their CD4 counter-
parts as they acquired regulatory markers and functions in culture,
and as a significant fraction of them reacted to F in a TCR specific
manner.
Decreased Frequency of DP8a LPL and PBL and
Decreased F-Reactivity of DP8a PBL in Patients with
Inflammatory Bowel Diseases Compared with Healthy
Donors
As F is present at reduced levels in the gut microbiota of patients
with IBD [2–4,28,29], we asked whether the frequencies of DP8a
LPL and PBL were altered in patients with IBD compared with
non-IBD donors (Tables S4 and S5 for characteristics of patients
and healthy individuals). The mean frequency of DP8a lympho-
cytes amongst CD3 LPL was lower in the inflamed colonic mucosa
of patients with IBD than in the healthy colonic mucosa of patients
with CC (respectively, 4.8%, range 0.9–9.9 and 8.5%, range 3.1–
16) (Figure 7a). Moreover, the mean fraction of DP8a lymphocytes
amongst CD3 PBL was lower for patients with IBD than for
healthy donors (respectively, 0.5%, range 0.1–1.3 and 1.5%, range
0.1–5.7) (Figure 7b). Separate analysis of the frequency of DP8a
PBL in patients with Crohn disease (n=20) and ulcerative colitis
(UC) (n=14) also indicated that in both diseases the frequency of
these cells was lower than in healthy donors, respectively, mean
fraction 0.4 and 0.6 range 0.1–1.2 and 0.2–1.3 (Figure 7b).
The reduced level of F. prausnitzii in the gut microbiota of Crohn
disease [2–4,28,29] and UC patients might affect the production
of F-specific Treg. To assess this hypothesis, we compared the
proliferative responses to F of DP8a PBL from healthy individuals
and patients with IBD. DP8a PBL from healthy donors
proliferated systematically upon PBMC co-culture with F
(Figure 7c), but not when cultured alone or with E (unpublished
data). A similar proliferation was observed among the PBMC from
nine out of 21 patients with IBD (Figure 7c). However, in the
remaining 12 patients, DP8a PBL did not proliferate or
proliferated only non-specifically, i.e., as much to E and/or in
the absence of bacteria as to F. This lack of specific response was
observed in particular with the PBMC from the five patients with
UC included in this assay (unpublished data). As a result, the mean
specific response to F of DP8a PBL from patients with IBD was
lower than in healthy donors: respectively, mean percent divided
cells among DP8a PBL, 7.5 and 2.4, ranges 1–22 and 0–14
(Figure 7c). Because patients with Crohn disease with ileal
involvement (L1 and L3 stages of the Montreal classification)
exhibit the clearest deficit in F in the gut microbiota, we assessed
whether remission in these patients was associated with a restored
frequency and/or response of DP8a PBL to F. DP8a PBL from L1
and L3 patients in remission (n=4) proliferated specifically to F
(mean percent divided cells: 6.4 range 2–12.7). Such a response
was significantly less frequent in patients with active disease (two
out of ten), mean percent F-specific divided cells 1.3 range 0–7
(Figure 7d). However, no significant difference in the frequency of
DP8a circulating T cells was observed between the patients in
remission and those in flair (unpublished data).
Finally, we could assess the proliferative response to F and E of
LPL freshly isolated from the inflamed mucosa of two patients with
UC and the IL-10/IFN-c response of an LPL line obtained from
the inflamed mucosa of another patient with UC. Similarly to
what we had observed with the PBL from many patients, freshly
isolated DP8a LPL (Figure 7e) and the LPL line (unpublished
data) failed to respond to F in contrast to freshly sorted LPL
populations (Figure 7e) and to LPL lines from healthy controls
(Figure 4a).
Discussion
Herein we demonstrated that DP8a T cells, present in the
human colonic LP and blood, represent a novel subset of T cells
lacking Foxp3 but sharing with Foxp3 Treg most other regulatory
markers and in vitro regulatory functions, and with Tr1 Treg the
capacity to secrete IL-10. We also showed that a great part of these
cells specifically recognized F. prausnitzii, a Clostridium cluster IV
bacterium, that is a major component of the indigenous gut
microbiota frequently decreased in patients with IBD [25]. In
addition, we showed that DP8a cells are decreased in the blood
Table 1. HLA Class II isotype restriction of F. prausnitzii recognition by LPL lines.
LPL
Lines Mix of Monocytes 2, 8, and 22
No Bacteria F F+Anti MHCII F+Anti-CD4 F+Anti-MHCI F+Anti-CD8 F+Anti-DP F+Anti-DQ F+Anti-DR
C 114 1.2a 23.2 5.5 5.4 23.7 33.1 9.9 14 27.5
C 139 0.8 42.8 8.3 7.9 39.6 26.6 23.3 9.4 26
C 140 0.6 13.3 0.9 0.8 12.9 19.2 15.2 15.2 1.3
DP8a LPL lines (n= 3, C114, C139, C140) were stimulated, in the presence or not of blocking antibodies, by a mix of three allogeneic monocytes, loaded overnight by F.
aPercent IL-10 or IFN-g positive cells.
doi:10.1371/journal.pbio.1001833.t001
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and colonic mucosa of patients with IBD compared with healthy
individuals and the healthy colonic mucosa of patients with CC,
respectively.
Together with the recent findings that bacteria of the Clostridium
IV and XIV clusters induced the development of IL-10-secreting
Foxp3 Treg in the colonic mucosa of germ-free mice and that
some of these cells were specific for antigens of the inducing
clostridia [9] [26], our results argue that DP8a T cells are Treg
similarly induced in the human colonic mucosa through cognate
activation by F. prausnitzii antigens. Thus, our data highlight a
homology between mice and humans regarding colonic Treg
induction by Clostridium bacteria. We also observed the presence of
low fractions of DP8a lymphocytes in the epithelium of the colonic
mucosa. However, as the phenotype and functions of these IEL
were not characterized further, it remains unclear whether they
correspond to the same Treg subset as DP8a LPL or to a colonic
mucosa-specific IEL subset.
In mice, two subsets of CD4CD8aa T lymphocytes have been
described in the epithelium of the small intestine [15,30,31]. One
of these shared with DP8a LPL the capacity to secrete IL-10 and
could prevent Th1-induced intestinal inflammation in an IL-10
dependent manner [15]. Interestingly studies with IL-10 reporter
mice indirectly showed that this subset is absent from the mouse
colonic LP, as far as all the IL-10-secreting lymphocytes of this
compartment expressed Foxp3 [16]. This suggests that human
DP8a and mouse Foxp3 LPL, both induced by Clostridium
bacteria in the colonic mucosa, may be functional and develop-
mental equivalents, in which case the distinct phenotype of these
peripherally induced Treg populations represents a species-related
divergence.
Whether Foxp3 Treg, induced by the microbiota, coexist with
DP8a Treg in the human colonic mucosa is unknown. We
observed that Foxp3+CD25highCD127low T cells represented a
much lower fraction of colonic LPL than DP8a Treg and did not
react with F (unpublished data).
Another subset of CD4CD8a IEL of the mouse small intestine
has been characterized recently as cytotoxic T lymphocytes.
Interestingly the expression of the co-receptor CD8aa and of the
cytotoxic function by CD4 IEL was shown to be associated with
down-regulation of ThPOK and up-regulation of Runx 3
transcription factors [30,31]. In contrast, the human DP8a LPL
expressed ThPOK and Runx 3 at same levels as their CD4
counterparts and lacked perforin and CD107a expression
(unpublished data).
Since, the induction of mouse colonic Foxp3 Treg required a
mix of at least three Clostridia strains [9,26], we asked whether
nine Clostridia strains that are common in human faeces might be
involved in the induction of DP8a Treg. Interestingly, four of these
belonged to a mix of the 17 human Clostridial strains that
enhanced Foxp3 Treg abundance in the mouse colonic mucosa
[26]. None of these Clostridium strains was recognized by DP8a
Treg. This showed that the target antigens of colonic DP8a Treg
are not shared Clostridium antigens but rather are species specific.
This further suggested that F is a major inducer of DP8a colonic
Treg. However, it does not exclude that other bacteria including
the Clostridium that induced Foxp3 Treg development in GF mice
[26], could play a role in this induction, independently of TCR
triggering. Besides cognate activation, DP8a Treg differentiation
likely requires additional signals. TGF-b, vitamin A-derived
retinoic acid, and tolerogenic DCs are Treg inducers constitutively
present within the gut mucosa [11]. Interestingly, the production
of these factors, within the mouse colon, has been shown to be
stimulated by Clostridi [9].
Further supporting a prevalent role of F in the induction of
colonic DP8a LPL, we observed that 80% of the freshly purified
DP8a LPL from one donor reacted to F antigens (Figure 4d).
Alterations in the composition of the gut microbiota and
especially reduced levels of F are characteristics of patients with
IBD [2–4,28]. Additionally, in ileal Crohn disease, F reduction
correlates with an increased risk of post-operative recurrence,
suggesting that disruption of the F level is involved in the
pathogenesis [2]. Importantly, the frequency of DP8a PBL and,
among these, the frequency of the F-specific cells were decreased
Table 2. Restriction of LPL responses to F by autologous HLA
class II alleles.
MonocytesLPL
C114 C139 C192
1 +a + +
DP*0201b, DQ*0202,
DR*0701
DP*0201, DP*0401DP*0401
2 2c + +
None DP*0401 DP*0401
3 2 + +
None DP*0401 DP*0401, DR*1501
4 2 2 2
None None None
5 + + +
DP*0201, DR*0701 DP*0201 None
6 2 2 2
None None None
7 2 2 2
None None None
DP8a LPL lines (n=3, C114, C139, C192) were stimulated, for 6 h by allogeneic
monocytes from seven HLA typed donors (Table S2) loaded overnight by F.
aMonocyte inducing a response to F.
bShared HLA allele.
cMonocyte that did not induce a response to F.
doi:10.1371/journal.pbio.1001833.t002
Table 3. Specificity of DP8a-LPL lines and-PBL lines for F.
prausnitzii.
Clostridium C114 C139 C140 DTC4
F. prausnitzii 29a 22.7 46.5 26
S. variabile 1.3 1 0.5 0
R. intestinalis 1 1.2 1 0.5
C. coccoides 0.7 0.9 1.5 0
C. leptum 1 1 0.5 0.5
R. gnavus 0.5 0 1 1
C. ramosum 1.2 1 0 0.5
C. symbosium 1 0.5 0.5 1.2
C. boltea 0.5 1 1 1
A. colihominis 1 1 0 0.5
DP8a LPL lines (n=3, C114, C139, C140) and one PBL line (DTC4) were
stimulated for 6 h by monocytes, loaded overnight by different Clostridium
species (1:5).
aPercent IL-10 or IFN-c positive cells.
doi:10.1371/journal.pbio.1001833.t003
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in patients with IBD compared with healthy donors. In addition,
DP8a lymphocytes were less frequent in the inflamed colonic
mucosa of patients with IBD compared with healthy colonic LP of
patients with CC. These observations may support a role of DP8a
Treg in the control of IBD. However, the decreased frequency of
DP8a LPL in the colonic mucosa of patients with IBD remains to
be established by comparison with healthy donors. Indeed the use
of individuals with CC as a control group has two main caveats.
One is the great age disparity between the patients with IBD and
with CC (Table S5). The other is the potential alteration of DP8a
colonic LPL frequencies, which may be associated in these patients
with gut microbiota dysbiosis especially F decrease [32].
The decreased frequency of DP8a PBL in patients with IBD
together with the reported decrease of F in the faeces of these
patients suggests that there is a connection between reduced levels
of F and decreased F-specific regulatory activity, potentially
resulting in increased inflammation. However, a formal assessment
needs to be done of the correlation between the levels of F and the
levels of DP8a PBL and LPL in patients with IBD. Moreover, the
nature of the potential connection between F and DP8a Treg
levels remains unclear. F decrease might limit the differentiation or
survival of DP8a Treg. Conversely, a defect in DP8a Treg
differentiation or function might contribute to dysbiosis, as
suggested in mice when the differentiation of Foxp3 Treg was
blocked [33].
DP8a LPL and PBL, at variance with their CD4 counterparts,
express high levels of the regulatory markers CD25, CTLA-4,
GITR, and LAG-3, secrete IL-10, and mediate robust inhibition
of CD4 T cell proliferation and of DC maturation. Therefore,
these cells appear adequately fitted to inhibit effector T cell
responses under both inflammatory and non-inflammatory con-
ditions [6,24]. These cells also expressed IFN-c and TNF-a and
Th-associated transcription factors. Similar expressions have
recently been observed in mouse and human Foxp3 Treg and
appear to represent phenotypic and functional specializations of
these cells, paralleling those of Th lymphocytes during inflamma-
tory responses [34–37]. Importantly, a number of studies have
established that IFN-c produced by Foxp3 Treg has essential
immune regulatory functions [38].
Although DP8a Treg and Tr1 cells secrete IL-10, several
phenotypic differences between them indicate that they represent
distinct Treg populations. Among these is the expression by DP8a
Treg of CD8a, high levels of CD25 and Gata-3, ex vivo and as cell
lines, and the lack of expression by these cells of PD1 (unpublished
data), considered to be a canonical marker of Tr1 cells by
Roncarolo and colleagues [39]. In addition, both Treg seem to use
different suppressive mechanisms as Tr1 suppression strongly
depends on IL-10 and TGF-b activity, while these molecules,
respectively, had a limited and no contribution to the suppressive
activity of DP8a Treg (Figure 3d). Nonetheless, IL-10, the main
inducer of Tr1 [13,14], might also contribute to DP8a Treg
induction as F is strong inducer of IL-10 secretion by peripheral
mononuclear cells [2].
No clear function could be ascribed so far to CD4CD8 PBL. We
showed that among these the DP8a subset lacked Treg markers ex
vivo, but acquired such markers and Treg functions in culture and
that a fraction of them reacted specifically to F. The fraction of F-
reactive DP8a PBL seems to be lower than that of DP8a LPL.
Indeed, at most 26.9% (mean 14.4%) of DP8a PBL reacted to F in
an autologous antigen presentation context. As between 20% and
40% of T cells are usually non-responsive to their antigen in vitro
(as observed with human clones), it may be estimated that no more
than 40% of ex vivo DP8a PBL may be specific for F. Therefore,
the remaining DP8a PBL should have distinct antigen specificities.
Whether these cells are specific for other gut bacteria or for
commensal strains present in other tissues is an interesting
question. Alternatively, as DP8a PBL lacked Treg markers ex
vivo, an important question was whether the fraction of these cells
not-reactive to F could be effector lymphocytes expanded in
response to infections, as suggested by others [20]. The
observation that the majority of DP8a PBL expressed CTLA-4
and LAG-3 independently of their specificity for F, after a few days
of culture with F, while very few of their CD4 counterparts
expressed these markers (Figure 5d) argues that most DP8a PBL
are Treg. It is likely that the circulating DP8a lymphocytes specific
for F had been induced in the gut mucosa. The capacity of pTreg
induced in the gut mucosa to recirculate in the blood was
documented in mice by the increased frequencies of IL-10-
secreting Treg outside the gut following Clostridium reconstitution
of GF mice [9].
The frequency of DP8a PBL was significantly reduced in the
blood of patients with Crohn disease and UC. In addition, in a
majority of these patients DP8a PBL failed to react to F,
suggesting that the decrease in circulating DP8a PBL may
specifically concern the F-specific ones. Alternatively, the defective
response to F might be due to immunomodulatory treatments.
However, this explanation appears unlikely because this defect was
not observed in some of the patients who underwent the same
treatments. It will be important to investigate if the frequency of
circulating F-specific DP8aTreg is correlated with the level of F
and to address its prognostic and diagnostic value.
The physiological significance of circulating microbiota-reactive
Treg will be important to address also in non-IBD contexts. In
mice, increased resistance to experimental colitis and allergy
models was observed in Clostridium-abundant animals. This
suggests that the proportion of gut Clostridium may affect both
colonic homeostasis and systemic immune responses and lead to
conclude that Clostridium-induced Treg mediate these effects [9].
Likewise, the circulating F-reactive Treg identified in our study
may play a role in systemic immunity. The quantification of DP8a
PBL in diseases associated with microbiota imbalance should
provide an answer to this question.
Figure 5. Presence of F-reactive DP8a T lymphocytes in the blood of healthy individuals. (a) Flow cytometry analysis of the frequencies of
DP8a T lymphocytes in the blood of 18 donors: representative dot plot of PBMC co-labelled with anti-CD3, anti-CD4, and anti-CD8a antibodies,
representative histogram of CD8b expression by gated CD8, CD4, and DP8a PBMC, and the percentages of DP8a lymphocytes among the CD3 and
the CD3CD4 PBMC. (b) Proliferative responses of DP8a peripheral blood T cells to F in the presence or absence of an anti-MHC class-II antibody or an
irrelevant antibody, and to B, L, and E. PBMC were cultured for 5 d with the antibody and/or indicated bacteria at a bacterium:PBMC ratio 1:1:
representative FlowJo analysis of the VPD dilution and percentage of F-specific divided DP8a T cells in the PBMC from several donors (n= 18); ***p,
0.001 and **p,0.01 (paired t-test). (c) Percent VPD dilution in paired DP8a and CD4 T cells among PBMC co-cultured with F for 5 d; ***p,0.001
(paired t-test). (d) CTLA4 and LAG3 expression in proliferative DP8a and CD4 PBL after 5 d of co-culture with allogeneic monocytes loaded overnight
with F (n= 2). (e) Flow cytometry analysis of the proliferative response of freshly isolated DP8a or CD4 PBL after 5 d of co-culture with autologous
monocytes alone or loaded overnight with F or E: representative cytometry data of a freshly sorted DP8a PBL population and mean percentage of F-
specific divided cells (calculated on FlowJo software) (experiments performed with five freshly isolated DP8a PBL (black circles) and two CD4 PBL
(white circles).
doi:10.1371/journal.pbio.1001833.g005
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Figure 6. DP8a PBL lines are phenotypically and functionally similar to DP8a LPL lines. (a) Left and middle: representative staining and
gating options used in the two successive sorts performed to obtain the DP8a PBL lines (n=4); middle and right: phenotype of the lymphocytes
obtained following polyclonal T cell expansion of the first and second sort, respectively, and representative histogram of CD8a and CD8b expression
by DP8a PBL lines. (b) The DP8a PBL lines (n=4) had a Treg phenotype (full line white histograms), in contrast with CD4 PBL lines (n= 3) (dotted line
white histograms) (isotype control: grey histograms). (c) IL-10 secretion by two DP8a PBL lines and their CD4 homologues, upon stimulation with
anti-CD3 antibody as measured by ELISA. (d) Representative in vitro inhibition of CD4 T lymphocyte proliferation by the DP8a PBL lines as in Figure 3b
(n=6: two experiments performed with three cell lines). (e) Representative inhibition of DC maturation by DP8a PBL lines as in Figure 3a (n= 6: two
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Importantly, the high in vitro proliferative capacity of DP8a cell
lines, together with the high stability of their regulatory functions,
are critical properties towards the use of these cells for adoptive
transfer purposes.
In conclusion, we have identified an unanticipated new subset of
Treg induced by F. prausnitzii that may contribute to the
suppression of deleterious inflammation in humans. Importantly,
these Treg exhibit a stable phenotype that allows their quantifi-
cation. These results may provide new diagnostic and therapeutic
strategies for IBD and systemic diseases that are associated with
abnormal induction and/or function of DP8a Treg. These results
should also lead to a much broader understanding of the impact of
the microbiota on the human immune system than the one we
currently have.
experiments performed with three cell lines). (f) IL-10 and IFN-c responses of the DP8a PBL lines to monocytes loaded or not with F, B, L, or E, as in
Figure 4c: representative dot plots and percentages of IFN-c and IL-10 secreting cells (three experiments performed with two to three cell lines).
***p,0.001 (paired t-test). (g) Representative dot plot of an optimal IL-10 and IFN-c response to F of a DP8a PBL line stimulated as in (f).
doi:10.1371/journal.pbio.1001833.g006
Figure 7. DP8a LPL and PBL, and the PBL reactivity to F, are decreased in patients with IBD. (a) Representative dot plots and frequencies
of DP8a lymphocytes among CD3 LPL freshly dissociated from the inflamed mucosa of patients with IBD (right plot and black circles, n= 14) and
healthy colon mucosa from patients with CC (left plot and white circles, n= 18); *p,0.05 (t-test). (b) Representative dot plots and frequencies of DP8a
PBL in healthy donors (white circles, n= 38), patients with IBD (black circles, n= 36), patients with UC (grey circles, n= 14), and patients with Crohn
disease (grey circles, n= 22); ***p,0.001 (t-test). (c) Flow cytometry analysis with the FlowJo software of the proliferative response (percent of F-
specific divided cells) of DP8a PBMC from healthy donors (HD) (n=21) or patients with IBD (n=25), after 5 d of culture with F; ***p,0.001 (t-test). (d)
As in (c) percent F-responder cells (F-specific DP8a divided cells) among PBMCs from L1 and L3 patients with Crohn disease in remission (R) and with
active disease (A); *p,0.05 (Mann-Whitney test). (e) Flow cytometry analysis with the FlowJo software of the proliferative response (percent of F-
specific divided cells) of DP8a lymphocytes among LPL freshly isolated from healthy mucosa (white circles, n= 3) and UC mucosa (black circles, n= 2),
following stimulation for 5 d by a mix of allogeneic monocytes isolated from the blood of three healthy donors and previously incubated overnight
with F.
doi:10.1371/journal.pbio.1001833.g007
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Methods
Cell Isolation and Cell Line Generation
PBMC were obtained from patients with IBD and healthy
individuals (see Table S4 for characteristics of patients with IBD
and healthy donors). Normal and inflamed colonic mucosa were
obtained, respectively, from patients undergoing surgery for CC
who did not undergo radiotherapy or chemotherapy, and from
patients undergoing surgery for IBD (Crohn disease or UC) (see
Table S5 for characteristics of patients with IBD and CC).
Monocytes and PBL were obtained from healthy donor blood by
elutriation (DTC platform, CHU, Nantes, France). Normal
colonic mucosa was obtained from surgically resected tissue, taken
approximately 10 cm downstream of the tumour. For normal
mucosa, the LP was separated from the epithelium after
incubation in EDTA buffer (30 min) and then minced into 1-
mm2 fragments and washed with RPMI containing penicillin
(10%) and gentamycin (0.1 mg/ml; Sigma-Aldrich). Tissue
fragments were digested with collagenase and DNAse (2 mg/ml
each; Sigma-Aldrich), with shaking at 37uC. Mucus and
large debris were removed by filtration through a 40-mm-cell
strainer (BD). Viable cells were obtained by Ficoll gradient
centrifugation.
This study was approved by the ethics committee of the Comite´
de Protection des Personnes Ile-de-France IV (Suivithe`que). All
the patients signed informed consent forms. For cell line
generation, CD3CD4CD8aneg and CD3CD4CD8alow LPL and
PBL were isolated, by sorting on a FACS-Aria (Becton Dickinson).
T cell lines were generated by stimulations with PHA, irradiated
feeder cells, and IL-2, as described [40]. For suppression assays of
T cell proliferation, CD4 T cells were isolated from PBMC using
magnetic beads (130-045-101; Miltenyi). Immature DC were
obtained from monocytes cultured for 5 d at 26106 cells/ml with
80 ng/ml IL-4 and 90 ng/ml GM-CSF (AbCys) in RPMI 1640
supplemented with L-glutamine, penicillin-streptomycin (10 mg/
ml) (GIBCO) and 10% SVF (PAA). DC maturation was induced
by co-culture with activated CD4 lymphocyte or CD4 cell lines
expressing the CD40L.
Flow Cytometry
The DP8a LPL subpopulation was identified by co-staining
with PerCP-conjugated anti-CD3 (345766), FITC-conjugated
anti-CD4 (555346), and APC-conjugated anti-CD8a (555369) or
anti-CD8b antibodies (641058) or their isotype control. The
DP8a PBL were identified by co-staining with the same anti-
CD3, anti-CD4, and anti-CD8a or anti-CD8a isotype control
antibodies (as above), and by gating on CD3CD4 cells expressing
lower amounts of CD8a than CD8ab T cells do. The marker
combinations and gating options used for the quantification of
DP8a LPL and PBL are described in Figures S1 and S5,
respectively. For phenotype determination, the following anti-
bodies were used: phycoerythrin (PE)-conjugated anti-CD25
(555432), anti-CTLA4 (555853), anti-LAG3 (514782), anti-
CD40L (335853), anti-LFA1 (555384), anti-LFA3 (555921),
anti-ICAM1 (555511), anti-FOXP3 (17477771), anti-GATA3
(560574), anti-TBET (125825), anti-RORcc (12698880) (all from
Becton Dickinson), anti-CD80 (IM2729U), anti-CD83
(IM2218U), anti-CD86 (IM1976U), anti-GITR (FAB689), (Beck-
man), and PE-conjugated anti-human TCR Vb chains (Immu-
notech Beckman Coulter). The following colour- and isotype-
matched control antibodies were used to confirm the staining
specificities: APC-conjugated mouse IgG1 (555751), PE-conju-
gated-mouse IgG1 (555749), and PE-conjugated-mouse-IgG2ak
(555574). Single-stained beads (Comp beads; Becton Dickinson)
for each fluorochrome were used for compensation settings. Cells
(26105) were stained in PBS/0.1% BSA containing antibodies for
30 min at 4uC in the dark. The cells were washed and 104 to 105
cells were acquired in the CD3 cell gate, on a FACScalibur or a
Canto II flow cytometer and analyzed using Diva or CellQuest
softwares (BD). The data were further analyzed with FlowJo
software (Tree Star).
Suppressive Assays: Inhibition of CD4 Proliferation and
DC Maturation
Freshly sorted CD4 PBL (56104) were incubated with 5 mM
CFSE (Invitrogen) in PBS containing 0.1% BSA for 15 min,
washed, and then stimulated with anti-CD3/anti-CD28 activa-
tion beads (Miltenyi) at a 1:1 ratio, in the presence or absence of
DP8a or CD4 LPL lines at the indicated effector:target (E:T)
ratios and in the presence or absence of anti-IL-10 or anti-TGF-b
antibodies. The proliferation of target CD4 T cells was assessed
by flow cytometry analysis of CFSE dilution among CD8-
negative T cells, on day 5. CD40L expressing CD4 LPL lines
were cultured with immature DC (1:1 ratio) for 2 to 3 d (to
induce DC maturation) in the presence or absence of DP8a cell
lines and of anti-CTLA-4 or anti-LFA-1 antibodies. The cells
were stained with APC-conjugated anti-CD3 (555335) and PE-
conjugated anti-CD80 (IM2729U) or PE-conjugated anti-CD83
(IM2218U), or PE-conjugated anti-CD86 (IM1976U) or isotype
control antibodies. CD3 negative cells were analyzed by flow
cytometry to determine the level of expression of CD80, CD83,
and CD86.
Intracellular Cytokine Assay
Lymphocytes were incubated 6 h with 0.1 mg/ml plate-bound
CD3 antibody (OKT3 eBioscience) or, at a 1:1 ratio, with bacteria
or monocytes (when autologous monocytes were not available a
mixture of monocytes from four donors were used to permit the
sharing of HLA class-II alleles between the monocytes and the
responding cells. Indeed, monocytes from a single donor that
lacked any MHC overlap failed to induce a response to F, as
shown on Table 2), previously incubated overnight with the
different bacteria at a 5:1 ratio. To prevent cytokine secretion,
10 mg/ml brefeldin A (Sigma-Aldrich) was added for the last 6 h of
stimulation. Stimulated cells were stained with PerCP-conjugated
anti-CD3, FITC-conjugated anti-CD4, and APC-conjugated anti-
CD8a. The cells were then fixed for 10 min in PBS/4%
paraformaldehyde (Sigma-Aldrich) and washed. Cytokine-specific
antibodies were then added for 30 min at room temperature.
Reagent dilutions and washes were performed with PBS contain-
ing 0.1% BSA and 0.1% saponin (Sigma-Aldrich). Cytokine
secretion was assessed by flow cytometry in DP8a or CD4-positive
LPL and cell lines. In some experiments TCR Vb and intracellular
labelling were analyzed among cytokine-labelled DP8a cell lines.
The following antibodies were used: PE-conjugated anti-IL-2
(559334), anti-IL-4 (554486), anti-IL-5 (554395), anti-IL-10
(562400), anti-TNF-a (554418), and anti-IL-22 (515303) and
APC-conjugated anti-IL-13 (554571), anti-IFN-c (554551), and
anti-IL-17 (51717871). We also used in some experiments anti-
CD3 Brilliant Violet (562426), anti-IFN-c APC (554702) com-
bined with the anti-IL-10 PE. For blocking experiments, we used
anti HLA class II ascites (clone 206 produced in our laboratory)
and an irrelevant mouse IgG.
IL-10 Production by ELISA
T cell lines (105 in 200 ml) were stimulated with plate bound
anti-CD3 antibody (OKT3, eBioscience) at 0.1 mg/ml for 2 d.
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The levels of IL-10 in the supernatants were measured by ELISA
(R&D Systems).
Bacterial Cultures
F. prausnitzii A2–165 (F) was grown for 20 h at 37uC in LYBHI
medium (brain–heart infusion medium supplemented with 0.5%
yeast extract; Difco), cellobiose (1 mg/ml; Sigma–Aldrich), malt-
ose (1 mg/ml; Sigma-Aldrich), and cysteine (0.5 mg/ml; Merck) in
an anaerobic chamber. B. thetaiotaomicron VPI-5482 (B) and L. casei
(ATCC 393) (L) were grown for 20 h at 37uC in an anaerobic
chamber in Wilkins-Chalgren medium (33 g/l; Oxoid) and LYBHI
medium, respectively. E. coli K12 (E) was grown for 20 h at
37uC with agitation (80 rpm) in Luria-Bertani medium (20 g/l;
Invitrogen). The supernatant and pellet for each bacterial
strain were obtained by centrifugation at 1,700 g at 4uC for
15 min.
T Lymphocyte Proliferation Assays to Bacteria
Lymphocytes (PBMC, LPL, PBL, or cell lines) were labelled for
15 min incubation at 37uC in the dark with 1 mM VPD (BD
Bioscience) in PBS containing 0.1% BSA. The cells were washed
twice in medium containing 10% FBS. F, B, L, and E were
sonicated for 15 min at high speed and then co-cultured with VPD
labelled PBMC at 1:1 ratio, or with monocytes overnight (at a
ratio 5:1) in presence of gentamycin (0.1 mg/ml). When autolo-
gous monocytes were not available a mix of allogeneic monocytes
from three to four donors was used to present the bacteria.
Monocytes, loaded with bacteria or left unloaded were washed
and mixed with VPD-labelled cells (1 to 1.56105) at a 1:5 ratio.
After 3 to 5 d, the proliferation of T cells was assessed by flow
cytometry analysis of the VPD dilution in CD3CD4CD8alow and
CD3CD4CD8aneg PBMC or in CD4- or in CD8a positive cells for
T cell lines and the fraction of divided cells was determined by
FlowJo analysis of the VPD dilution. The HLA class II
dependency was analyzed by adding a specific antibody every
48 h or an irrelevant mouse IgG.
Quantitative RT-PCR Analysis
Briefly, after cell lysis using the Trizol reagent (Life technolo-
gies), total RNA were extracted using the RNeasy Micro kit
(Qiagen) and reverse transcribed using the Superscript II reverse
transcriptase (Life technologies). PCR amplification was per-
formed with an amount of cDNA corresponding to 50 ng of total
RNA. For qPCR, amplification was done using iQ SYBR Green
Supermix (Bio-Rad) and specific gene expression was calculated
using the 2DDCT method (using GAPDH as calibrator). The
primer sequences used are available on request.
Statistical Analysis
Statistical analysis was performed with the GraphPad Prism
version 5.0 (GraphPad software). Paired and unpaired t-tests and
the Mann-Whitney test were used, as indicated in the Figures 1–7.
Differences were considered significant at p,0.05.
Supporting Information
Figure S1 Marker combinations and gating options
used for the quantification of DP8a cells among T
lymphocytes obtained from freshly dissociated LP
colonic samples.
(TIF)
Figure S2 DP8a among the IEL of healthy colonic
mucosa. Freshly dissociated IEL were analyzed by flow
cytometry for the co-expression of CD4 and either CD8a or
CD8b. Representative dot-plots and frequencies of CD4 T cells
co-expressing the CD8a or CD8b among CD3 IEL from eight
donors; **p,0.01 (paired t-test).
(TIFF)
Figure S3 Flow cytometry analysis of the gut homing/
localization markers and cytokine profile of DP8a LPL
lymphocytes from healthy colonic mucosa. (a–c) Freshly
dissociated CD3 LPL. (a) Expression of gut homing markers by
DP8a LPL. (b) Expression of transcription factors, as in Figure 1e.
(c) Cytokines secreted upon stimulation with anti-CD3 (as in
Figure 1f). (d) IL-10 m RNA expression in DP8a and CD4 LPL
lines (n=3).
(TIF)
Figure S4 Lack of regulatory functions and F reactivity
of CD4 LPL lines. (a) Flow cytometry figure showing the
proliferation of CD4 lymphocytes is inhibited by DP8a LPL line
C139 but not by its CD4 counterparts as measured by VPD
dilution. (b) Dot plot showing the proliferative response of a DP8a
LPL line (representative of four) upon stimulation with an anti-
CD3 antibody (measured by PKH26 dilution) in a co-culture with
VPD labelled CD4 T lymphocytes. (c) Flow cytometry analysis of
the intracellular cytokine response of DP8a LPL lines (n=3) and
autologous CD4 LPL lines (n=3), as in Figure 3b; ***p,0.001
(paired t-test).
(TIF)
Figure S5 Marker combinations and gating options
used for the quantification of DP8a cells among
freshly-isolated PBMC.
(TIF)
Table S1 Vb diversity of total DP8a and F-reactive
DP8a-cells among LPL lines and ex vivo LPL. Cytometry
analysis of Vb expressed by DP8a cells among LPL lines (n=2
C101, C114) stimulated# or not* by F-loaded monocytes and
among freshly purified LPL (C150) stimulated## or not** by F-
loaded monocytes. A gate was done on DP8a cells.
(XLSX)
Table S2 MHC class II alleles expressed by LPL lines
and monocytes.
(XLSX)
Table S3 Vb diversity of total DP8a and F-reactive DP8a-
cells among PBMC and PBL lines. Cytometry analysis of Vb
expressed by DP8a cells among PBMC* (n=2 DTC4, DTC28) and
among VPD-labelled cell lines derived from these PBMC (by a
single sorting and polyclonal expansion of DP8a cells) stimulated***
or not** by F-loaded monocytes. A gate was done on DP8a
cells.
(XLSX)
Table S4 Characteristics of the donors used to study
DP8a PBL.
(XLSX)
Table S5 Characteristics of the donors used to study
DP8a LPL.
(XLSX)
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